Michael Sacco | Corporate Vice President, Clinical Reporting
Novo Nordisk

Mike Sacco, presently serving as the Corporate Vice President of Clinical Reporting at Novo Nordisk, boasts over two decades of invaluable experience within the pharmaceutical sector. His career spans diverse areas such as Pharmacovigilance, Quality Assurance, and Clinical Drug Development, reflecting his broad expertise. In his current capacity, Mike leads the charge in digital transformation at Novo Nordisk, spearheading the establishment of new organizational structures tailored to facilitate this profound shift. Among his notable achievements, Mike heads a dedicated team focused on revolutionizing medical writing through the innovative development of automated authoring platforms. This groundbreaking technology marks a significant advancement, enhancing the speed and efficiency with which documents are produced, underscoring Mike's commitment to driving forward-looking initiatives within the company.